• Ziprasidone Hydrochloride (A5350): GOT1 Inhibition and Du...

  2026-02-19

  Ziprasidone Hydrochloride (Ziprasidone HCl, A5350) is a second-generation antipsychotic and potent serotonin/dopamine receptor antagonist with validated GOT1 inhibitory activity. This compound offers reproducible, quantitative benchmarks for disrupting tumor metabolism and modulating neurotransmitter pathways, making it a key tool in both neuroscience and cancer research. APExBIO provides a rigorously characterized formulation for translational workflows.

• Ziprasidone Hydrochloride: A Dual-Action GOT1 Inhibitor f...

  2026-02-18

  Explore the multifaceted role of Ziprasidone Hydrochloride as both a serotonin and dopamine receptor antagonist and a GOT1 inhibitor. This in-depth analysis uncovers its potential in cancer metabolism reprogramming and neuropsychiatric research, presenting new insights unavailable in existing resources.

• Ziprasidone Hydrochloride in Translational Research: Neur...

  2026-02-18

  Ziprasidone Hydrochloride stands out as a versatile research tool, bridging neuroscience and oncology through its dual actions as a serotonin and dopamine receptor antagonist and GOT1 inhibitor. This article provides actionable protocols, troubleshooting guidance, and future-focused insights for maximizing experimental impact with APExBIO’s trusted Ziprasidone HCl reagent.

• Ziprasidone Hydrochloride: Beyond Antipsychotic—A New Par...

  2026-02-17

  Explore Ziprasidone Hydrochloride’s unique dual role as a second-generation antipsychotic and potent GOT1 inhibitor for cancer research. This article delves into its advanced applications in disrupting tumor metabolism and modulating serotonergic and dopaminergic pathways, offering insights not found in conventional reviews.

• Ziprasidone Hydrochloride: A Paradigm Shift in GOT1-Targe...

  2026-02-16

  Explore how Ziprasidone Hydrochloride, a potent serotonin and dopamine receptor antagonist, uniquely disrupts tumor redox balance through GOT1 inhibition. This article delves into its dual applications in advanced cancer and neuroscience research, offering mechanistic insights and experimental strategies not found elsewhere.

• Ziprasidone Hydrochloride: Applied Neuroscience and Oncol...

  2026-02-16

  Ziprasidone Hydrochloride bridges neuroscience and oncology, empowering advanced research on dopaminergic signaling, serotonergic pathway modulation, and tumor metabolism. Explore stepwise protocols, formulation innovations, and expert troubleshooting for robust, reproducible results in both psychotic disorder models and cancer cell studies.

• Ziprasidone HCl: Applied Protocols for Neuroscience & Can...

  2026-02-15

  Ziprasidone Hydrochloride (Ziprasidone HCl) bridges neuroscience and oncology with validated protocols for receptor antagonism and GOT1 inhibition, setting a new bar for reproducibility in advanced research. Discover stepwise workflows, troubleshooting tips, and comparative advantages that empower robust assays and translational insights with this versatile APExBIO reagent.

• Ziprasidone Hydrochloride: Redefining Translational Lever...

  2026-02-14

  Explore how Ziprasidone Hydrochloride (Ziprasidone HCl) bridges neuroscience and oncology by combining potent serotonin/dopamine receptor antagonism with GOT1 inhibition. This thought-leadership article offers mechanistic depth, strategic guidance for translational researchers, and an actionable roadmap to harness its full potential—far beyond standard product pages.

• Ziprasidone HCl: Dual-Action Reagent for Neuroscience and...

  2026-02-14

  Ziprasidone Hydrochloride (Ziprasidone HCl) offers researchers a unique edge by combining potent serotonin and dopamine receptor antagonism with GOT1 inhibition, bridging neuroscience and oncology. With validated protocols, robust performance metrics, and APExBIO’s quality assurance, this versatile molecule enables advanced studies in psychotic disorder models and tumor metabolism.

• Ziprasidone Hydrochloride: Applied Workflows in Neuroscie...

  2026-02-13

  Ziprasidone Hydrochloride (Ziprasidone HCl) stands out as both a high-affinity serotonin and dopamine receptor antagonist and a GOT1 inhibitor, enabling dual use in advanced neuroscience and cancer research. This guide details optimized experimental workflows, troubleshooting strategies, and comparative advantages of APExBIO’s Ziprasidone Hydrochloride for translational studies targeting receptor signaling and tumor metabolism.

• Ziprasidone Hydrochloride (A5350): Mechanistic Insights &...

  2026-02-13

  Ziprasidone Hydrochloride (Ziprasidone HCl) is a potent serotonin and dopamine receptor antagonist with proven efficacy in both psychiatric and antitumor contexts. Its dual action as a GOT1 inhibitor and 5-HT2A/D2 antagonist positions it as a unique tool for both neuroscience and cancer metabolism research. Rigorous in vitro and in vivo studies validate its utility, and APExBIO offers a high-quality standard for laboratory workflows.

• Ziprasidone Hydrochloride: Novel Mechanistic Insights and...

  2026-02-12

  Explore the multifaceted role of ziprasidone hydrochloride as a serotonin and dopamine receptor antagonist and GOT1 inhibitor. This in-depth article uncovers new mechanistic insights, advanced applications in cancer and neuroscience research, and the impact of formulation innovations.

• Ziprasidone HCl: Optimizing Neuroscience & Cancer Workflows

  2026-02-12

  Ziprasidone Hydrochloride (Ziprasidone HCl) sets a new standard for dual-pathway research as both a serotonin/dopamine receptor antagonist and GOT1 inhibitor. This guide delivers actionable protocols, troubleshooting strategies, and advanced applications—empowering researchers to drive breakthroughs in atypical antipsychotic and cancer metabolism studies.

• Ziprasidone Hydrochloride: Bridging Dopaminergic and Onco...

  2026-02-11

  Ziprasidone Hydrochloride (Ziprasidone HCl) transcends its established role in neuropsychiatric therapeutics, emerging as a versatile tool for both neuroscience and oncology researchers. This thought-leadership article unpacks the compound’s unique dual mechanisms—serotonin/dopamine receptor antagonism and GOT1 inhibition—while offering strategic guidance for translational scientists. Drawing on mechanistic insights, recent formulation advances, and expert recommendations, we chart a forward-thinking roadmap for maximizing Ziprasidone Hydrochloride's impact in preclinical innovation.

• Optimizing Cell Assays with Ziprasidone Hydrochloride (SK...

  2026-02-11

  This article addresses persistent challenges in cell viability, proliferation, and cytotoxicity assays by exploring real laboratory scenarios where Ziprasidone Hydrochloride (SKU A5350) provides reproducible, quantitative solutions. Drawing on validated concentrations, mechanistic detail, and workflow experience, it guides biomedical researchers toward robust, data-backed assay design using this advanced APExBIO reagent.

443 records 27/30 page Previous Next First page 上5页 2627282930